SOURCE: ZELTIQ Aesthetics, Inc.

ZELTIQ Aesthetics, Inc.

December 18, 2015 16:05 ET

ZELTIQ to Present at the J.P. Morgan 34th Annual Healthcare Conference

PLEASANTON, CA--(Marketwired - December 18, 2015) - ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the J.P. Morgan 34th Annual Healthcare Conference in San Francisco, CA. This conference will allow institutional investors to meet with the company following their formal presentation.

Event: J.P. Morgan 34th Annual Healthcare Conference

Date: Wednesday, January 13, 2016

Time: 7:30 a.m. PT / 10:30 a.m. ET

An audio webcast of the Company's presentation will be available by visiting the investor relations section of ZELTIQ's web site at www.coolsculpting.com. A replay of the presentation will be available for 90 days.

About ZELTIQ ® Aesthetics, Inc.

ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.

Contact Information

  • CONTACTS:

    Investor Relations:
    Patrick F. Williams
    ZELTIQ
    Senior Vice President and CFO
    925-474-2500

    Nick Laudico
    The Ruth Group
    646-536-7030
    nlaudico@theruthgroup.com